.</p>

<p><em>Methysergide Maleate</em></p>

<p>Although methysergide maleate is currently unavailable in the United States, it is hoped that it may come back to the market for physicians to use for <span class="SearchCriteria">headache</span> treatment. Methysergide, an ergot derivative, is effective in 65 to 69% of cases of episodic <span class="SearchCriteria">cluster</span> <span class="SearchCriteria">headache</span>s, but it is not commonly used because of its association with potentially serious,